医疗科技公司Fathom近日宣布获得西维斯健康旗下风险投资部门CVS Health Ventures的战略投资。此项投资将用于加速Fathom企业级自主编码技术的研发与推广，进一步提升医疗账单编码自动化水平。
通过本次战略合作，Fathom将借助西维斯健康在医疗领域的资源优势，扩大其人工智能驱动编码解决方案的应用规模。该技术能有效提升医疗机构的运营效率，降低人工编码错误率，实现医疗账单处理的智能化转型。
此次合作标志着大型医疗保健企业对自动化编码技术前景的认可。随着医疗行业数字化转型加速，自主编码技术有望成为提升医疗运营效率的关键突破口。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.